We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current TKNO market cap is 412.07M. The company's latest EPS is USD -0.6900 and P/E is -11.16.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Total Revenue | 11.53M | 8.17M | 7.87M | 9.29M | 9.61M |
| Operating Income | -7M | -6.57M | -13.05M | -7.99M | -5.1M |
| Net Income | -7.15M | -10.15M | -10.66M | -8.1M | -5.36M |
| Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 31.3M | 36.89M | 41.42M | 36.68M |
| Operating Income | 4.66M | -12.01M | -49.66M | -35.56M |
| Net Income | 3.57M | -9.8M | -47.47M | -36.78M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Total Assets | 132.55M | 138.39M | 128.59M | 120.82M | 115.35M |
| Total Liabilities | 46.34M | 38.73M | 38.55M | 37.44M | 36.43M |
| Total Equity | 86.21M | 99.65M | 90.04M | 83.38M | 78.93M |
| Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 62.91M | 166.51M | 152.26M | 128.59M |
| Total Liabilities | 10.51M | 23.31M | 52.38M | 38.55M |
| Total Equity | 52.41M | 143.2M | 99.89M | 90.04M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Operating | -11.54M | -15.92M | -18.81M | -6.56M | -9.4M |
| Investing | -6.65M | -7.62M | -7.74M | 13k | -102k |
| Financing | -205k | 13.42M | 12.8M | -343k | -390k |
| Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 2.51M | -9.07M | -27.4M | -18.81M |
| Investing | -1.74M | -17.52M | -28.15M | -7.74M |
| Financing | -1.6M | 110.79M | 10.27M | 12.8M |
| Market Cap | 412.07M |
| Price to Earnings Ratio | -11.16 |
| Price to Sales Ratio | 11.19 |
| Price to Cash Ratio | 14.41 |
| Price to Book Ratio | 4.56 |
| Dividend Yield | - |
| Shares Outstanding | 53.31M |
| Average Volume (1 week) | 212.81k |
| Average Volume (1 Month) | 201.72k |
| 52 Week Change | 132.83% |
| 52 Week High | 8.9086 |
| 52 Week Low | 1.155 |
| Spread (Intraday) | 1.66 (19.17%) |
| Company Name | Alpha Teknova Inc |
| Address |
108 w. 13th street suite 100 wilmington, delaware 19801 |
| Website | https://www.teknova.com |
| Industry | in vitro,in vivo diagnostics (2835) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
